In episode 66, hosts Kevin Schaefer and Michael Morale discuss news regarding the FDA-approved treatment Evrysdi, and Michael’s decision to switch to this therapy. They also talk about the clinical trial drug SRK-015, which is developed by Scholar Rock. Finally, Kevin reads excerpts from some of our recent columns.

================================

To learn more about Evrysdi, please visit http://www.ApprovedForSMA.com

================================

To take part in our ongoing discussions regarding SMA, please visit http://www.smanewstoday.com/forums

================================

For the most up-to-date information regarding SMA, please visit http://www.smanewstoday.com